Biogen Idec (NASDAQ: BIIB) today announced that Richard (Rick) A. Rudick, M.D., has joined the company as vice president, Development Sciences, Value-Based Medicine.
Dr. Rudick will lead Biogen Idec’s newly created Value-Based Medicine Group, which will focus on using new technology to develop innovative programs and tools to better understand, measure and manage the treatment of multiple sclerosis (MS).
Help employers find you! Check out all the jobs and post your resume.
